We are live on
!
Find out more
NPP
New Potomac Partners Portfolio holdings
AUM
$195M
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.28%
1 Year Est. Return
+30.7%
3 Year Est. Return
+37.18%
5 Year Est. Return
+102.97%
10 Year Est. Return
–
AUM
$107M
AUM Growth
+$7.2M
(+7.2%)
Cap. Flow
-$206K
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
31.43%
Holding
140
New
2
Increased
25
Reduced
39
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.84M |
| 2 |
AbbVie
ABBV
|
+$1.01M |
| 3 |
Invesco Preferred ETF
PGX
|
+$433K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$295K |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$269K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$1.39M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.25M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$279K |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$166K |
| 5 |
iShares Biotechnology ETF
IBB
|
+$138K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 31.14% |
| 2 | Financials | 14.82% |
| 3 | Technology | 13.48% |
| 4 | Healthcare | 11.75% |
| 5 | Communication Services | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Enterprise Products Partners
EPD
$84.2B
| $11K | 0.01% |
400
| – | – |
|
127
Vanguard Total Bond Market
BND
$163B
| $10K | 0.01% |
123
+18
| +17% | +$1.51K |
|
128
iShares MSCI Israel ETF
EIS
$916M
| $9K | 0.01% |
150
| – | – |
|
129
iShares Russell Mid-Cap ETF
IWR
$56.7B
| $9K | 0.01% |
150
| – | – |
|
130
Public Service Enterprise Group
PEG
$37.1B
| $9K | 0.01% |
150
| – | – |
|
131
Vanguard Short-Term Bond ETF
BSV
$46.4B
| $8K | 0.01% |
100
| – | – |
|
132
Simon Property Group
SPG
$68B
| $7K | 0.01% |
50
| – | – |
|
133
Peloton Interactive
PTON
$2.25B
| $6K | 0.01% |
200
| – | – |
|
134
ProShares Russell 2000 Dividend Growers ETF
SMDV
$699M
| $6K | 0.01% |
100
| – | – |
|
135
Charter Communications
CHTR
$17.6B
| $3K | ﹤0.01% |
6
| – | – |
|
|
BFS
136
Saul Centers
BFS
$800M
| – | – |
-325
| Closed | -$18K |
|
|
137
FedEx
FDX
$74.6B
| – | – |
-9,545
| Closed | -$1.39M |
|
|
JBGS
138
JBG SMITH
JBGS
$683M
| – | – |
-885
| Closed | -$35K |
|
139
Wabtec
WAB
$47.4B
| – | – |
-24
| Closed | -$2K |
|
|
CELG
140
DELISTED
Celgene Corp
CELG
| – | – |
-12,575
| Closed | -$1.25M |
|
Similar funds
AI
GAM
TRAM
MSCM
AWM
BA
BMMM
ARCM
New Potomac Partners's Q4 2019 Portfolio in Review
As of Q4 2019, New Potomac Partners held 140 positions worth $107M, up 7.2% from $100M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
New Potomac Partners's Q4 2019 filing shows 2 new, 25 increased, 39 reduced and 5 closed positions. Its largest new stake was Gilead Sciences: 28,240 shares worth $1.83M. The largest sale was FedEx, an estimated $1.39M.
By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, down from 31% a quarter earlier, followed by Financials and Technology.
- New Potomac Partners's largest Q4 2019 buy was Gilead Sciences: 28,240 shares worth $1.83M.
- New Potomac Partners added most to AbbVie in Q4 2019, an estimated $1.01M increase.
- New Potomac Partners's biggest Q4 2019 reduction was iShares Floating Rate Bond ETF, cutting an estimated $279K.
- New Potomac Partners fully exited FedEx in Q4 2019, selling an estimated $1.39M.
- New Potomac Partners's ten largest holdings make up 31% of its $107M portfolio in Q4 2019.
- New Potomac Partners opened 2 new positions and closed 5 in Q4 2019.
- New Potomac Partners's portfolio value rose 7.2% quarter-over-quarter to $107M.
Based on New Potomac Partners's 13F filing for Q4 2019, filed 23 Jan 2020.